281 related articles for article (PubMed ID: 20725825)
21. Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes.
Santos A; Bakker AD; Zandieh-Doulabi B; Semeins CM; Klein-Nulend J
J Orthop Res; 2009 Oct; 27(10):1280-7. PubMed ID: 19353691
[TBL] [Abstract][Full Text] [Related]
22. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts.
Bakker AD; Kulkarni RN; Klein-Nulend J; Lems WF
J Dent Res; 2014 Apr; 93(4):394-9. PubMed ID: 24492932
[TBL] [Abstract][Full Text] [Related]
23. Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model.
Simfia I; Schiavi J; McNamara LM
Exp Cell Res; 2020 Jul; 392(1):112005. PubMed ID: 32330507
[TBL] [Abstract][Full Text] [Related]
24. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
[TBL] [Abstract][Full Text] [Related]
25. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
[TBL] [Abstract][Full Text] [Related]
26. HIF-1α facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro.
Zhu J; Tang Y; Wu Q; Ji YC; Feng ZF; Kang FW
J Cell Physiol; 2019 Nov; 234(11):21182-21192. PubMed ID: 31032948
[TBL] [Abstract][Full Text] [Related]
27. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
Liu XH; Kirschenbaum A; Yao S; Levine AC
Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
[TBL] [Abstract][Full Text] [Related]
28. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
[TBL] [Abstract][Full Text] [Related]
29. MEPE expression in osteocytes during orthodontic tooth movement.
Gluhak-Heinrich J; Pavlin D; Yang W; MacDougall M; Harris SE
Arch Oral Biol; 2007 Jul; 52(7):684-90. PubMed ID: 17270144
[TBL] [Abstract][Full Text] [Related]
30. Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.
David V; Martin A; Hedge AM; Rowe PS
Endocrinology; 2009 Sep; 150(9):4012-23. PubMed ID: 19520780
[TBL] [Abstract][Full Text] [Related]
31. Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes.
Wang Z; Weng Y; Ishihara Y; Odagaki N; Ei Hsu Hlaing E; Izawa T; Okamura H; Kamioka H
PeerJ; 2020; 8():e10244. PubMed ID: 33240612
[TBL] [Abstract][Full Text] [Related]
32. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
Honma M; Ikebuchi Y; Kariya Y; Suzuki H
Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
[TBL] [Abstract][Full Text] [Related]
33. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
34. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
[TBL] [Abstract][Full Text] [Related]
35. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
36. Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte.
Cui L; Li XT; Zhang D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):207-11. PubMed ID: 22776650
[TBL] [Abstract][Full Text] [Related]
37. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
[TBL] [Abstract][Full Text] [Related]
38. MT1-MMP modulates the mechanosensitivity of osteocytes.
Kulkarni RN; Bakker AD; Gruber EV; Chae TD; Veldkamp JB; Klein-Nulend J; Everts V
Biochem Biophys Res Commun; 2012 Jan; 417(2):824-9. PubMed ID: 22202174
[TBL] [Abstract][Full Text] [Related]
39. Osteoclast differentiation by RANKL and OPG signaling pathways.
Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
[TBL] [Abstract][Full Text] [Related]
40. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
Sapir-Koren R; Livshits G
Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
